The Industry 6.0 technologies adoption is revolutionizing the healthcare and pharmaceutical sectors by enhancing efficiency, precision, and sustainability. AI is optimizing drug discovery, accelerating clinical trials, and enabling predictive diagnostics, reducing time to market for new treatments. The Internet of Medical Things (IoMT) ensures real-time patient monitoring, while CPS enhance robotic-assisted surgeries and automated laboratory processes, improving accuracy and patient outcomes. Quantum computing is transforming molecular simulations, enabling the design of highly specific drug compounds, while blockchain technology is securing pharmaceutical supply chains, minimizing counterfeit drugs. Advanced 3D and 4D bioprinting facilitates the production of customized prosthetics, tissue engineering, and even organ regeneration, addressing critical transplant shortages. The pharmaceutical industry is leveraging nanotechnology for targeted drug delivery, improving bioavailability, and reducing side effects. Smart manufacturing driven by AI, digital twins, and automation is minimizing waste, ensuring cost efficiency, and enhancing regulatory compliance. Wearable health technologies and biosensors enable personalized medicine, optimizing treatments based on individual genetic profiles. As healthcare systems transition towards predictive and precision medicine, Industry 6.0 innovations will redefine patient care, pharmaceutical development, and global healthcare accessibility, contributing to sustainable healthcare solutions aligned with the SDGs.